Stock listing
ASX:FRE Firebrick Pharma Limited Share Price
Follow Firebrick Pharma Limited into a list and get an email when it puts out news.
Share price · ASX:FRE
$0.027 AUD -0.003 (-10.0%)
Close on Nov 20, 2026
- Day range
- $0.027 – $0.027 AUDNov 20, 2026
- Volume
- 11,476 sharesNov 20, 2026
- Market cap
- $8.32M AUDAt the close on Nov 20, 2026 · price × 308.1M shares outstanding
- 52-week range
- $0.024 – $0.070 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2,848 AUDMedian day 17,000 shares · 15 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:FRE · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.027 | -0.003 | -10.0% | $0.027 | $0.027 | $0.027 | 11,476 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | +0.002 | +7.1% | $0.030 | $0.030 | $0.030 | 2,243 | |
| $0.028 | -0.002 | -6.7% | $0.028 | $0.028 | $0.028 | 2,678 | |
| $0.030 | -0.001 | -3.2% | $0.032 | $0.032 | $0.030 | 63,238 | |
| $0.031 | +0.002 | +6.9% | $0.028 | $0.031 | $0.028 | 339,262 | |
| $0.029 | +0.001 | +3.6% | $0.029 | $0.031 | $0.029 | 15,178 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 2,000 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 100,000 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 68,444 | |
| $0.028 | 0.000 | 0.0% | $0.030 | $0.031 | $0.028 | 123,202 | |
| $0.028 | +0.001 | +3.7% | $0.028 | $0.028 | $0.028 | 30,840 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 0 | |
| $0.027 | -0.001 | -3.6% | $0.027 | $0.027 | $0.027 | 3,674 | |
| $0.028 | -0.003 | -9.7% | $0.028 | $0.028 | $0.028 | 20,564 | |
| $0.031 | +0.002 | +6.9% | $0.031 | $0.031 | $0.031 | 17,500 | |
| $0.029 | -0.001 | -3.3% | $0.028 | $0.029 | $0.028 | 14,297 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.028 | 34,259 | |
| $0.030 | +0.002 | +7.1% | $0.027 | $0.030 | $0.027 | 32,966 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.030 | $0.028 | 47,000 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | -0.005 | -15.2% | $0.031 | $0.031 | $0.028 | 564,525 | |
| $0.033 | +0.003 | +10.0% | $0.031 | $0.035 | $0.031 | 878,569 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | +0.001 | +3.4% | $0.028 | $0.030 | $0.028 | 241,974 | |
| $0.029 | -0.002 | -6.5% | $0.029 | $0.029 | $0.029 | 17,244 | |
| $0.031 | +0.002 | +6.9% | $0.030 | $0.031 | $0.030 | 656,957 | |
| $0.029 | +0.001 | +3.6% | $0.029 | $0.029 | $0.029 | 620,077 | |
| $0.028 | +0.001 | +3.7% | $0.028 | $0.028 | $0.028 | 45,731 | |
| $0.027 | -0.001 | -3.6% | $0.028 | $0.028 | $0.027 | 8,190 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 17,000 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | -0.001 | -3.4% | $0.028 | $0.028 | $0.028 | 60,000 | |
| $0.029 | +0.001 | +3.6% | $0.029 | $0.029 | $0.026 | 278,532 | |
| $0.028 | +0.002 | +7.7% | $0.030 | $0.030 | $0.028 | 256,595 | |
| $0.026 | 0.000 | 0.0% | $0.026 | $0.026 | $0.026 | 1,060 | |
| $0.026 | -0.001 | -3.7% | $0.026 | $0.026 | $0.026 | 14,317 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 30,784 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 18,029 | |
| $0.027 | -0.001 | -3.6% | $0.028 | $0.028 | $0.027 | 223,482 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 425 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 0 | |
| $0.028 | -0.003 | -9.7% | $0.032 | $0.032 | $0.028 | 861,484 | |
| $0.031 | +0.001 | +3.3% | $0.030 | $0.031 | $0.030 | 36,662 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 7,531 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 2,000 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | +0.001 | +3.4% | $0.030 | $0.030 | $0.030 | 4,400 | |
| $0.029 | 0.000 | 0.0% | $0.029 | $0.029 | $0.029 | 0 | |
| $0.029 | -0.003 | -9.4% | $0.029 | $0.029 | $0.029 | 102,675 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.032 | 14,700 | |
| $0.032 | -0.003 | -8.6% | $0.035 | $0.035 | $0.032 | 10,888 | |
| $0.035 | +0.001 | +2.9% | $0.030 | $0.035 | $0.030 | 87,702 | |
| $0.034 | -0.001 | -2.9% | $0.034 | $0.034 | $0.034 | 32,872 | |
| $0.035 | +0.002 | +6.1% | $0.030 | $0.035 | $0.030 | 46,276 | |
| $0.033 | +0.001 | +3.1% | $0.029 | $0.033 | $0.029 | 44,599 | |
| $0.032 | +0.003 | +10.3% | $0.031 | $0.032 | $0.031 | 213,195 | |
| $0.029 | 0.000 | 0.0% | $0.029 | $0.029 | $0.029 | 55,000 | |
| $0.029 | +0.002 | +7.4% | $0.029 | $0.029 | $0.029 | 10,000 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 0 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 0 | |
| $0.027 | -0.001 | -3.6% | $0.028 | $0.028 | $0.027 | 15,000 |
- Ticker
- ASX:FRE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 16, 2026
Notification regarding unquoted securities - FRE
Latest deck · Oct 7, 2026
Aussie Equities Day, Singapore 2026
Conference · 15 slides
Latest news
Notification regarding unquoted securities - FRE
Nov 16, 2026
Closed $0.03 (+7.1%) on Nov 17, 2026
Change of Director's Interest Notice - Stephen Goodall
Nov 16, 2026
Closed $0.03 (+7.1%) on Nov 17, 2026
Change of Director's Interest Notice - Rick Legleiter
Nov 16, 2026
Closed $0.03 (+7.1%) on Nov 17, 2026
Change of Director's Interest Notice - Peter Molloy
Nov 16, 2026
Closed $0.03 (+7.1%) on Nov 17, 2026
Change of Director's Interest Notice - Al Moghaddam
Nov 16, 2026
Closed $0.03 (+7.1%) on Nov 17, 2026
Proposed issue of securities - FRE
Nov 11, 2026
Closed $0.031 (+6.9%) on Nov 12, 2026
Results of Annual General Meeting
Nov 10, 2026
Closed $0.029 (+3.6%) on Nov 11, 2026
September 2026 Quarterly Activity Report & Appendix 4C
Oct 22, 2026
Closed $0.03 (0.0%) on Oct 23, 2026
New Product - Nasodine Sinus Rinse
Oct 20, 2026
Closed $0.028 (0.0%) on Oct 21, 2026
Change in substantial holding - Pharma Nutria
Oct 19, 2026
Closed $0.028 (0.0%) on Oct 20, 2026
Firebrick Pharma Limited on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 35 in the last 12 months · 92 in all · newest Nov 16, 2026 · oldest 2022
- Decks
- 9 decks · latest Oct 7, 2026
Cash and shares
Oct 2026 deck · Firebrick Pharma — Aussie Equities Day, Singapore 2026
- Cash
- $1.32 million
Valuation
EV/sales 66.0× against a median of 0.9×: the highest of 11 Pharmaceuticals companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $7.00M AUD
- P/E
- Loss
- EV/sales
- 66.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.0×
- Gross margin
- −977.1%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Firebrick Pharma Limited · ASX:FRE | US$5.51M | US$4.63M | n/a | 66.0× | n/a | 5.0× | n/a | 0.0× | n/a |
| Biofrontera Inc. · NASDAQ:BFRI | US$9.51M | US$13.83M | n/a | 0.3× | n/a | n/a | −12.7% | n/a | 1.96 |
| Optimi Health Corp. · CSE:OPTI | US$9.18M | US$67,053 | n/a | 0.6× | n/a | 0.8× | n/a | 0.0× | 1.08 |
| ChoA Pharmaceutical Co., Ltd. · KRX:034940 | US$6.55M | US$6.85M | n/a | 0.1× | n/a | 0.3× | −4.6% | 0.1× | n/a |
| Newbury Pharmaceuticals AB · OMXSTO:NEWBRY | US$5.79M | US$4.87M | n/a | 1.2× | n/a | 3.0× | −53.7% | 0.0× | n/a |
| Universe Pharmaceuticals INC · NASDAQ:UPC | US$5.41M | −US$14.09M | n/a | 0.0× | n/a | 0.1× | −20.6% | 0.2× | 0.91 |
| Mangalam Drugs & Organics Ltd. · NSE:MANGALAM | US$4.71M | US$4.71M | n/a | 0.2× | n/a | 0.4× | −16.5% | 0.0× | n/a |
| Vivimed Labs Limited · NSE:VIVIMEDLAB | US$4.49M | US$46.54M | n/a | 6.2× | n/a | n/a | −252.1% | n/a | n/a |
| Acrux Limited · ASX:ACR | US$4.05M | US$4.59M | n/a | 1.5× | n/a | 4.2× | −13.0% | 1.7× | n/a |
| Scilex Holding Company · NASDAQ:SCLX | US$3.98M | US$98.96M | n/a | 3.1× | n/a | n/a | n/a | n/a | 1.46 |
| Scienture Holdings, Inc. · NASDAQ:SCNX | US$3.74M | US$8.36M | n/a | 5.6× | n/a | 0.1× | n/a | 0.2× | 1.74 |
| Median of the others | US$5.06M | US$5.86M | 0.9× | 0.4× | −16.5% | 0.1× | 1.46 |
Team and board
Officers
| Officer | Role |
|---|---|
| Peter Molloy | Co-Founder & Executive Director |
| Stephen Goodall | Co-Founder & Executive Director |
Board
| Director | Role |
|---|---|
| Peter Molloy | Co-Founder & Executive Director |
| Stephen Goodall | Co-Founder & Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 29, 2025 | −1.3% |
| Q2 2025 | Feb 20, 2025 | +1.2% |
| Q2 2023 | Feb 17, 2023 | +4.9% |
| Q4 2022 | Aug 23, 2022 | −6.8% |
| Q2 2022 | Jan 25, 2022 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Aussie Equities Day, Singapore 2026 | Conference | 15 slides | Oct 7, 2026 |
| Investor Presentation (March 2026) | Investor deck | 18 slides | Mar 4, 2026 |
| Shareholder Meeting (November 2025) | Shareholder meeting | 24 slides | Nov 26, 2025 |
| Investor Presentation (June 2025) | Investor deck | 20 slides | Jun 23, 2025 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 18 slides | Nov 27, 2024 |
| Conference Presentation (October 2023) | Conference | 22 slides | October 2023 |
| Euroz Hartleys Healthcare Forum 2023 | Conference | 20 slides | Feb 1, 2023 |
| Shareholder Meeting (November 2022) | Shareholder meeting | 28 slides | Nov 23, 2022 |
| Euroz Hartleys Rottnest Island Institutional Conference 2022 | Conference | 13 slides | Mar 11, 2022 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of securities Announced: private placement | Nov 11, 2026 | |
| Strategic investment of ordinary fully paid shares Closed: A$732,000 raised · A$0.035 a share Buyers: Pharma Nutria N.A. Inc. ($631,750, increasing its holding in Firebrick to just over 10.0%) Use of proceeds: New production for US retail distribution, production and launch in Singapore of a new Nasodine product, and working capital | Oct 18, 2026 | US$510,774 |
| Private placement of securities Announced: private placement | Oct 11, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 106.0K | 293.4K | 14.5K | 830 | 4.12K | 422.0K | 509.0K | 0 |
| Cost of revenue | 1.14M | 188.6K | 37.3K | 520 | 301 | 451 | ||
| Gross profit | -1.04M | 104.8K | -22.8K | 830 | 4.12K | 421.5K | 508.7K | -451 |
| Research and development | 549.3K | 735.2K | 1.91M | 4.09M | 2.22M | 1.13M | 1.63M | 1.06M |
| Selling, general and administrative | 1.25M | 297.8K | 217.8K | 292.2K | 503.9K | 857.6K | 36.6K | 10.6K |
| Operating income | -3.10M | -2.87M | -3.93M | -6.86M | -3.36M | -2.86M | -2.01M | -1.17M |
| Depreciation and amortization | 4.58K | 8.62K | 7.18K | 9.52K | 6.94K | 520 | 301 | 451 |
| EBITDA | -3.10M | -2.86M | -3.92M | -6.85M | -3.35M | -2.86M | -2.01M | -1.17M |
| Interest expense | 9.18K | 1.01K | 4.14K | 0 | 0 | 0 | ||
| Income before tax | -3.09M | -2.63M | -1.18M | -6.82M | -3.80M | -2.86M | -2.01M | -1.17M |
| Income tax | -28.8K | -222.1K | -2.74M | -21.7K | -1.08M | -422.0K | -509.0K | -445.0K |
| Net income | -3.06M | -2.63M | -1.18M | -6.80M | -3.80M | -2.44M | -1.50M | -725.3K |
| Earnings per share, basic | -0.01 | -0.01 | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | -0.00 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.32M | 983.4K | 824.8K | 2.35M | 7.14M | 10.9M | 92.7K | 577.5K |
| Short-term investments | 283.2K | |||||||
| Receivables | 50.1K | 257.8K | 951.0K | 137.4K | 1.08M | 503.1K | 560.6K | 502.3K |
| Inventory | 363.3K | 194.0K | 239.8K | 98.5K | ||||
| Current assets | 1.86M | 1.48M | 2.09M | 2.59M | 8.33M | 11.7M | 654.2K | 1.18M |
| Property, plant and equipment | 94.5K | 26.8K | 33.9K | 41.8K | 16.2K | 604 | 910 | |
| Total assets | 2.17M | 1.83M | 2.41M | 2.98M | 8.73M | 11.8M | 654.8K | 1.18M |
| Accounts payable | 202.3K | 113.0K | 68.9K | 197.5K | 36.3K | 34.7K | 203.8K | 43.2K |
| Current liabilities | 483.0K | 271.3K | 291.1K | 506.4K | 450.1K | 214.8K | 209.8K | 43.2K |
| Total debt | 54.4K | 54.4K | ||||||
| Total liabilities | 483.0K | 271.3K | 291.1K | 506.4K | 450.1K | 214.8K | 264.2K | 97.6K |
| Shareholders' equity | 1.68M | 1.56M | 2.12M | 2.48M | 8.28M | 11.6M | 390.6K | 1.08M |
| Shares outstanding | 254.3M | 210.3M | 179.0M | 170.1M | 168.8M | 168.8M | 168.8M | 168.8M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2.60M | -1.78M | -2.34M | -5.78M | -4.20M | -1.94M | -985.0K | -1.06M |
| Capital spending | -5 | -83.0K | -134 | -1.62K | -32.5K | -16.1K | -16.1K | 0 |
| Free cash flow | -2.60M | -1.86M | -2.35M | -5.78M | -4.23M | -1.95M | -985.0K | -1.06M |
| Cash from investing | -83.0K | -134 | -1.62K | -32.5K | -16.1K | -16.1K | ||
| Cash from financing | 2.94M | 2.02M | 815.2K | 996.7K | 10.2M | 3.01M | 500.3K | 1.26M |
| Share buybacks | -126.6K | -27.4K | -5.29K | -6.26K | -474.1K | 3.13M | 407.8K | 686.7K |
| Change in cash | 338.1K | 158.6K | -1.53M | -4.79M | 5.99M | 1.06M | -484.8K | 194.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Notification regarding unquoted securities - FRE | Nov 16, 2026 | Other filings | ASX |
| Change of Director's Interest Notice - Stephen Goodall | Nov 16, 2026 | Ownership change notice | ASX |
| Change of Director's Interest Notice - Rick Legleiter | Nov 16, 2026 | Ownership change notice | ASX |
| Change of Director's Interest Notice - Peter Molloy | Nov 16, 2026 | Ownership change notice | ASX |
| Change of Director's Interest Notice - Al Moghaddam | Nov 16, 2026 | Ownership change notice | ASX |
| Proposed issue of securities - FRE | Nov 11, 2026 | Financing | ASX |
| Results of Annual General Meeting | Nov 10, 2026 | Meeting outcome | ASX |
| September 2026 Quarterly Activity Report & Appendix 4C | Oct 22, 2026 | Quarterly report | ASX |
| New Product - Nasodine Sinus Rinse | Oct 20, 2026 | Operations update | ASX |
| New Product - Nasodine Sinus Rinse | Oct 20, 2026 | Operations update | ASX |
All 92 filings
Cap table
Built by 6ix from Firebrick Pharma Limited’s releases · as of Nov 11, 2026
- Common shares
- 308,106,128
- Fully diluted
- 308,106,128
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 308,106,128 | Oct 18, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 18, 2026 | 308,106,128 |
Log in to ask 6ix AI your own questions about Firebrick Pharma Limited.